Home
Kyverna Therapeutics KYTX paid Brownstein Hyatt Farber Schreck $20K for lobbying in Q1 2026 · Pharmacy
Trade details
- Type
- Lobbying report
- Amount
- $20,000
- Quarter
- Q1 2026
- Client
- Kyverna Therapeutics
- Reported
- 26/04/19
$80K on lobbying this year
What else happened in Kyverna Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Kyverna Therapeutics's other lobbying reports
- Kyverna Therapeutics
LobbyingKyverna Therapeutics
LobbyingKyverna Therapeutics
KYTX
$60K
$60K
Reported 07/20
for Q2
- Kyverna Therapeutics
LobbyingKyverna Therapeutics
LobbyingKyverna Therapeutics
KYTX
$60K
$60K
Reported 07/17
for Q2
- Kyverna Therapeutics
LobbyingKyverna Therapeutics
LobbyingKyverna Therapeutics
KYTX
$60K
$60K
Reported 04/20
for Q1
- Kyverna Therapeutics
LobbyingKyverna Therapeutics
LobbyingKyverna Therapeutics
KYTX
$50K
$50K
Reported 01/20
for Q4 2025